Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: Veterinary Drug Retail Sales Audit in Russia (December 2019 and Full Year)

Wednesday, February 5, 2020

The volume of Russian households’ purchases of veterinary drugs amounted to 20.6 bln RUB (retail prices, VAT included) in 2019. The volume of purchases in physical terms is over 110 mln units (or over 199 mln MDUs), including veterinary products sold in single-unit packages.

The Central Federal District is the leader with 34.2% of the country’s purchases in monetary and 24.4% in physical terms (7.1 mln RUB, or 26.8 mln units). Moscow is the leader in the district, with 17.4% in monetary and 8.3% in physical terms. Moscow is followed by the Moscow region with 8.5% and 5.3%.

The Russian manufacturing companies account for 37.7% of the market in monetary terms and 59.9% in physical terms. However, the top 10 manufacturing companies in monetary terms include only 3 Russian ones. Agrovetzashchita is the absolute leader among the Russian companies, taking up second place with 8.9% of the market in monetary terms and first place in physical terms. The company manufactures one in six units of veterinary drugs bought by Russian households. The other two Russians companies, Apicenna and Skiff, took sixth and tenth place, respectively.

The total number of foreign manufacturing companies in the household segment is 92. The US companies account for 30.8% of the market in monetary and 15.7% in physical terms. MSD tops the ranking with 16.9% in monetary and 6% in physical terms. Another US company, Zoetis, comes third with 8.5% in monetary and 6.4% in physical terms. The other foreign companies in the ranking include those of Germany, France, and Slovenia. The largest German company in the ranking is Bayer Healthcare, coming fourth with 6.8% in monetary and 3.4% in physical terms.

Top 10 animal pharmaceutical companies in terms of purchases by Russian households, 2019